132 related articles for article (PubMed ID: 38289195)
1. Comment on: Can Intranasal Nalmefene Reduce the Number of Opioid Overdose Deaths?
Skolnick P
Clin Pharmacol Drug Dev; 2024 Mar; 13(3):317-318. PubMed ID: 38289195
[No Abstract] [Full Text] [Related]
2. Can Intranasal Nalmefene Reduce the Number of Opioid Overdose Deaths?
Sellers EM; Romach MK
Clin Pharmacol Drug Dev; 2024 Mar; 13(3):315-316. PubMed ID: 38289185
[No Abstract] [Full Text] [Related]
3. Pharmacokinetic Properties of an FDA-approved Intranasal Nalmefene Formulation for the Treatment of Opioid Overdose.
Crystal R; Ellison M; Purdon C; Skolnick P
Clin Pharmacol Drug Dev; 2024 Jan; 13(1):58-69. PubMed ID: 37496452
[TBL] [Abstract][Full Text] [Related]
4. Nalmefene returns for reversal of opioid overdose.
Med Lett Drugs Ther; 2022 Sep; 64(1658):141-142. PubMed ID: 36094553
[No Abstract] [Full Text] [Related]
5. Fighting Fire with Fire: Development of Intranasal Nalmefene to Treat Synthetic Opioid Overdose.
Krieter P; Gyaw S; Crystal R; Skolnick P
J Pharmacol Exp Ther; 2019 Nov; 371(2):409-415. PubMed ID: 30940694
[TBL] [Abstract][Full Text] [Related]
6. Stronger, longer, better opioid antagonists? Nalmefene is NOT a naloxone replacement.
Infante AF; Elmes AT; Gimbar RP; Messmer SE; Neeb C; Jarrett JB
Int J Drug Policy; 2024 Feb; 124():104323. PubMed ID: 38232438
[TBL] [Abstract][Full Text] [Related]
7. American College of Medical Toxicology and the American Academy of Clinical Toxicology position statement: nalmefene should not replace naloxone as the primary opioid antidote at this time.
Stolbach AI; Mazer-Amirshahi ME; Nelson LS; Cole JB
Clin Toxicol (Phila); 2023 Nov; 61(11):952-955. PubMed ID: 38039052
[TBL] [Abstract][Full Text] [Related]
8. Nalmefene nasal spray (Opvee) for reversal of opioid overdose.
Med Lett Drugs Ther; 2023 Oct; 65(1687):166-167. PubMed ID: 37871116
[No Abstract] [Full Text] [Related]
9. Binding of a new opiate antagonist, nalmefene, to rat brain membranes.
Michel ME; Bolger G; Weissman BA
Methods Find Exp Clin Pharmacol; 1985 Apr; 7(4):175-7. PubMed ID: 2991678
[TBL] [Abstract][Full Text] [Related]
10. Nalmefene: a long-acting opioid antagonist. Clinical applications in emergency medicine.
Wang DS; Sternbach G; Varon J
J Emerg Med; 1998; 16(3):471-5. PubMed ID: 9610980
[TBL] [Abstract][Full Text] [Related]
11. Longer occupancy of opioid receptors by nalmefene compared to naloxone as measured in vivo by a dual-detector system.
Kim S; Wagner HN; Villemagne VL; Kao PF; Dannals RF; Ravert HT; Joh T; Dixon RB; Civelek AC
J Nucl Med; 1997 Nov; 38(11):1726-31. PubMed ID: 9374341
[TBL] [Abstract][Full Text] [Related]
12. Management of precipitated opiate withdrawal syndrome induced by nalmefene mistakenly prescribed in opiate-dependent patients: a review for clinicians.
Franchitto N; Jullian B; Salles J; Pelissier F; Rolland B
Expert Opin Drug Metab Toxicol; 2017 Jun; 13(6):669-677. PubMed ID: 28343423
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness and safety of intravenous nalmefene for emergency department patients with suspected narcotic overdose: a pilot study.
Kaplan JL; Marx JA
Ann Emerg Med; 1993 Feb; 22(2):187-90. PubMed ID: 8427429
[TBL] [Abstract][Full Text] [Related]
14. Opioid substitution therapy or hidden opioids are a minefield for nalmefene: an atypical case series of 11 patients in Lorraine.
Yéléhé-Okouma M; Martini H; Lemarié J; Labroca P; Petitpain N; Gibaja V; Paille F; Gillet P
Fundam Clin Pharmacol; 2017 Oct; 31(5):574-579. PubMed ID: 28322465
[TBL] [Abstract][Full Text] [Related]
15. Enhanced Intranasal Absorption of Naltrexone by Dodecyl Maltopyranoside: Implications for the Treatment of Opioid Overdose.
Krieter P; Gyaw S; Chiang CN; Crystal R; Skolnick P
J Clin Pharmacol; 2019 Jul; 59(7):947-957. PubMed ID: 30698833
[TBL] [Abstract][Full Text] [Related]
16. The opioid receptor antagonist nalmefene reduces responding maintained by ethanol presentation: preclinical studies in ethanol-preferring and outbred Wistar rats.
June HL; Grey C; Warren-Reese C; Durr LF; Ricks-Cord A; Johnson A; McCane S; Williams LS; Mason D; Cummings R; Lawrence A
Alcohol Clin Exp Res; 1998 Dec; 22(9):2174-85. PubMed ID: 9884166
[TBL] [Abstract][Full Text] [Related]
17. Double-blind, randomized study of nalmefene and naloxone in emergency department patients with suspected narcotic overdose.
Kaplan JL; Marx JA; Calabro JJ; Gin-Shaw SL; Spiller JD; Spivey WL; Gaddis GM; Zhao N; Harchelroad FP
Ann Emerg Med; 1999 Jul; 34(1):42-50. PubMed ID: 10381993
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the sites of opioid influence on anterior pituitary hormone secretion using a quaternary opiate antagonist.
Simpkins JW; Swager D; Millard WJ
Neuroendocrinology; 1991 Oct; 54(4):384-90. PubMed ID: 1661859
[TBL] [Abstract][Full Text] [Related]
19. Treatment of overdose in the synthetic opioid era.
Skolnick P
Pharmacol Ther; 2022 May; 233():108019. PubMed ID: 34637841
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
